The November deadline for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation. A Q&A with Allison Gilpin, Business Unit Manager, Global Serialisation, and Ray Hook, Manager Global Serialisation Services, PCI Pharma Services.

Comments are closed.